|drug586||COVID 19 diagnostic test by PCR Wiki||0.45|
|drug3616||Virtual Family-Based Treatment Wiki||0.45|
|drug3259||Supportive Therapy Wiki||0.45|
|drug2867||Reward Re-Training Wiki||0.45|
|drug3918||lung ultrasound Wiki||0.32|
|drug612||COVID-19 RT-PCR Wiki||0.26|
|D056912||Binge-Eating Disorder NIH||0.45|
|D001836||Body Weight Changes NIH||0.45|
|D001835||Body Weight NIH||0.45|
There are 5 clinical trials
COVID-19 lockdown presents particular challenges for people living with obesity. Indeed during this period, the lifestyle was deeply modified: diet, activity, and sleep behaviours, home office, take care of child, social distancing... All of these modifications may have led to stress and anxiety. It has been previously demonstrated that high perceived stress levels are correlated with high preference for sweet and fat foods . In this context caution would be exercised in obese patients especially those with binge eating disorders. Indeed binge eating disorder is characterized by compulsive overeating or consuming abnormal amounts of food while feeling unable to stop and a loss of control. And one key trigger of binge eating disorder is stress and anxiety. Thus, patients with binge eating disorders may have been more sensitive to the impact of lockdown and thus urgently would require appropriated care management. The main objective is to compare the eating behaviour between obese patients with or without binge eating disorders. The second objective is to compare the weight evolution between the two groups before and after the lockdown. To reach these objectives, the scientific team of the CIO project proposes to contact by phone and e-mail obese patients (with or without binge eating disorders) who have been hospitalized for their obesity disease before the start of the lockdown in the Endocrinology department of the Lyon Hospital. The patients will be asked to fill in several questionnaires (using an online tool) allowing to evaluate their mood, anxiety, eating behaviour, binge eating disorders… during the lockdown. The results of these questionnaires will be compared to those collected during their hospitalisation before the lockdown. The hypothesis is that participants suffering from binge eating disorder will have more sever eating behaviour perturbations as higher level of stress, anxiety, depressive symptoms.
Since March 17, 2020, the French government has implemented national containment measures due to the COVID-19 epidemic. Quarantine is an unpleasant experience : Separation from relatives, loss of liberty, concern about the infectious status, boredom, can negatively affect mental health, with the emergence of anxiety and depressive symptoms. In addition, confinement can disrupt usual physical activity, a major destabilization criterion for patients suffering from eating disorders (ED). Finally, conditions of confinement can harm social support, yet identified as a protective and resilience factor in stress contexts. Thus, the current context of confinement and social distances could be source of an increase in eating behavior disorders symptoms in people suffering from ED.
Description: the investigators aim to investigate the link between containment measuresMeasure: Variation in eating disorders Time: 1 month
Description: the investigators aim to investigate the link between ED symptomatology with EDE-Q (eating disorder evaluation, caractéristiques du TCA)Measure: Variation in eating disorders Time: 1 month
Description: The investigators aim to investigate the link between containment measuresMeasure: Vision of the bodily aspect Time: 1 month
Description: The investigators aim to investigate the link between body dissatisfactionMeasure: Vision of the bodily aspect Time: 1 month
Description: the investigators aim to investigate the link between containment measuresMeasure: Variation in physical activity Time: 1 month
Description: the investigators aim to investigate the link between physical activityMeasure: Variation in physical activity Time: 1 month
Description: the investigators aim to investigate the link between containment measuresMeasure: Identify the clinical factors modulating the psychological state during confinement Time: 1 month
Description: the investigators aim to investigate the link between emotional eatingMeasure: Identify the clinical factors modulating the psychological state during confinement Time: 1 month
Athletes in martial arts compete in categories separated by body weight, hence, many athletes need to adjust their habitual body weight during periods with competition preparation. Athletes competing in weight sensitive sports are previously identified with an increased risk for symptoms of low energy availability and of disordered eating. The methods used for body weight regulation are varied, and athletes without professional competent support, are prone to rely on harmful methods. And of importance, female athletes respond more negatively to attempts of body weight reduction with regards to health effects. Athletes of martial art are not surrounded by the same professional competence seen in other organized sports within the international sport federations, and specifically health competence is lacking. Additionally, numbers of females competing in martial art have increased the last decade, but they still practice in a sport culture dominated by males; both with reference to the high number of male participants, and with reference to the coaches within this sport. Sports involving practice in intimate, physical interaction with coaches or opposing athletes, and in sports where clothing is minimal, may be a high risk of experiences of sexual harassment. There have been a few reports on harmful methods of body weight regulation within martial arts, however, little knowledge exists on the practice by female martial art athletes, and the related health effects. Information on experiences of sexual harassment have been sparse in sport generally, with very little knowledge from sports like martial arts specifically. This study aims to explore the practice of female martial art athletes on body weight regulation, recovery strategies, their body acceptance and symptoms of eating disorders, and any experiences of sexual harassment. Additionally, with regards to the recent onset of the Covid-19 pandemic, this study also explores the related experiences by the athletes on training- and eating routines.
Description: Evaluating intensity in symptoms of low energy availability, with one general score, one subscale measuring symptoms of menstrual irregularities, and one subscale measuring symptoms of gastrointestinal dysfunction; the three scales having cut-off scores of ≥8 , ≥4 and ≥2, with higher scorings indicating higher clinical severity.Measure: Low energy availability for females questionnaire (LEAF-Q) Time: Autumn 2020
Description: Measuring symptoms of eating disorders and frequency of eating disordered behavior, resulting in one total score, and four subscales (figure concern, weight concern, eating concern and eating restriction). A total score of ≥2.5 indicates high probability of having an eating disorder. Additionally, the scales measures frequency of disordered eating behavior, for which ≥1 episode per week of binge-eating and/or ≥1 episode per week of purging behavior, over a total period of ≥3 months, qualifies for an diagnosis of eating disorder.Measure: Eating disorder examination questionnaire (EDE-q) Time: Autumn 2020
Description: Reports on methods complied with, to achieve body weight reduction (Predefined answers, including an "other" option)Measure: Body Weight regulation strategies, selfreported Time: Autumn 2020
Description: Evaluates the level of body appreciation and acceptance. Questionnaire contains 10-items with a Likert scale ranging from 1 (Never) to 5 (Always), with a higher average score indicating a higher level of body appreciation.Measure: Body appreciation scale (BAS-2) Time: Autumn 2020
Description: Information on exercise frequency (number of sessions per week)Measure: Exercise frequency, selfreported according to a designed questionnaire Time: Autumn 2020
Description: Information on duration of sessions (minutes per session)Measure: Exercise duration, selfreported according to a designed questionnaire Time: Autumn 2020
Description: Information on motivation for material arts (reason for choosing the sport, and what level of performance one aims for)Measure: Exercise motivation, selfreported according to a designed questionnaire Time: Autumn 2020
Description: Information on the different physical activities performed (reports number of different sport activities undertaken during a typical week)Measure: Exercise program variation, selfreported according to a designed questionnaire Time: Autumn 2020
Description: Level of physical activity (counts/minute) objectively measured for seven consecutive days using the ActiGraph accelerometer (ActiGraph GT3x and GT3x+, Actigraph, LCC, Pensacola, Florida, USA)Measure: Physical activity level, objectively measured Time: Autumn 2020
Description: Four day diet registration by pictures and detailed notes, for analyses of energyintake.Measure: Four day weighed diet registration; energyintake Time: Autumn 2020
Description: Four day diet registration by pictures and detailed notes, for nutrient analyses. The outcomes will specifically be analysed for total intake of protein, carbohydrate, and fat (gram per kg bodyweight)Measure: Four day weighed diet registration; nutrient intake Time: Autumn 2020
Description: Four day diet registration by pictures and detailed notes, for nutrient analyses. The outcomes will be analysed for total intake of micronutrients specifically found to be in risk of insufficient intake among young norwegian females (calcium, vit-D, folic acid, iodine) and considering their specific needs due to high levels of physically activity (iron and vitamin C) (all given by mg nutrient consumed)Measure: Four day weighed diet registration; nutrient intake Time: Autumn 2020
Description: Questions on experiences of sexual harassment, current experience of such, and frequency of such episodes.Measure: Experiences of sexual harassment Time: Autumn 2020
Description: Questions on whether covid-19 changed their normal exercise and diet routines (yes/no), if this related to increased or decreased training volume or change in activity preferences. Additionally, whether the pandemic period has changed their energy intake (increased/decreased).Measure: Effects from Covid-19 pandemic on exercise- and eating routines, designed questionnaire Time: Autumn 2020
In the current study, the investigators will revise our existing 10-session group RRT treatment manual to specifically address the challenges in building social support and enhancing both momentary and sustained reward during the COVID-19 pandemic (Preliminary Aim 1). In months 2-18, the investigators will conduct a small pilot RCT that will randomize individuals to receive either 10-sessions of RRT (n=30) or supportive therapy (n=30), both delivered as group-treatments via videoconferencing software. The specific aims of the current study are to confirm the feasibility and acceptability of RRT for EDs (Primary Aim 1), evaluate the ability of RRT to engage critical targets including reward to day-to-day life activities, reward to palatable foods, social isolation, and loneliness (Primary Aim 2), and provide preliminary estimates of efficacy in reducing ED symptoms at both post-treatment and a 3-month follow-up (Primary Aim 3). the investigators will also evaluate the impact of RRT on secondary outcome variables including depression, substance use, and quality of life (Secondary Aim 1).
Description: Frequency (number of instances) of binge eating over the past 28 days assessed by the Eating Disorder ExaminationMeasure: Binge eating frequency assessed by the Eating Disorder Examination Time: Changes from each assessment time point throughout treatment (3 assessments over 10 weeks) and 3-month post-treatment follow-up assessment
Description: The Eating Disorder Examination is a semi-structured interview that measures eating. pathology. The EDE yields a total eating pathology score that will be used as an outcome variable. Global eating pathology is on a 0-6 point scale with higher scores indicating more significant eating pathology.Measure: Global Eating Pathology Time: Changes from each assessment time point throughout treatment (3 assessments over 10 weeks) and 3-month post-treatment follow-up assessment
Description: Presence or absence of eating disorder diagnosis. Not in remission; in partial remission; or in full remission.Measure: Remission Status Time: Changes from each assessment time point throughout treatment (3 assessments over 10 weeks) and 3-month post-treatment follow-up assessment
Description: Frequency ( number of instances) of compensatory behaviors assessed by the Eating Disorder ExaminationMeasure: Compensatory behavior frequency assessed by the Eating Disorder Examination (EDE) Time: Changes from each assessment time point throughout treatment (3 assessments over 10 weeks) and 3-month post-treatment follow-up assessment
Description: Assesses the type (description of certain feelings or attitudes) and intensity (how often or how much the feelings and attitudes are present) of various depressive symptoms using a total score. The scale ranges from 0-63 with higher scores indicating worse depressive symptoms.Measure: Depressive symptoms as assessed by the Beck Depression Inventory-II Time: Changes from each assessment time point throughout treatment (3 assessments over 10 weeks) and 3-month post-treatment follow-up assessment
Description: Frequency of substance use (number of days/month)Measure: Substance Use assessed by the NIDA-Modified ASSIST Time: Changes from each assessment time point throughout treatment (3 assessments over 10 weeks) and 3-month post-treatment follow-up assessment
Description: Assesses the importance of 16 given life domains have on influencing happiness and current satisfaction level regarding these 16 life domains. Scores range from 1-77 with higher scores indicating better quality of life.Measure: Quality of Life assessed by the Quality of Life Inventory (QOLI) Time: Changes from each assessment time point throughout treatment (3 assessments over 10 weeks) and 3-month post-treatment follow-up assessment
The COVID-19 pandemic has had detrimental effects on mental health. Individuals with eating disorders (EDs) are no exception, exhibiting increased symptoms and exacerbated feelings of isolation and anxiety. Across Canada, in-person outpatient services have been quickly replaced with virtual care, yet practitioners and patients have noted substantial challenges in adapting ED-related care virtually. Given the success of our previous research on Family-Based Treatment (FBT) for EDs, as well as the rapid transition to virtual care during COVID-19, there is an urgent need to adapt FBT to virtual formats and adopt it in the ED network. Using a multi-site case study with a mixed method pre/post design, this study aims to examine the implementation of virtual FBT (vFBT) as well as its impact within six ED programs in Ontario, building on the investigator's previous work, and further developing capacity in the system. The investigator will develop implementation teams at each site and provide a virtual training workshop on vFBT, with ongoing consultation during initial implementation. The investigator proposes to examine implementation success by studying fidelity to vFBT, as well as team and patient/family experience with virtual care, and patient outcomes. These findings for virtual care will not only be important in the COVID-19 context but are also vital in the North, where access to specialized services is extremely limited.
Description: Measured by a self-report questionnaire entitled Key Measure of Therapist Behaviours and Self-Efficacy in FBT (an indicator of therapist adherence to the key components of standard FBT within the vFBT model)Measure: Key components of FBT Time: Completed after session 4 of treatment, approximately 4 months
Description: Fidelity to vFBT, measured by FBT fidelity ratings of the first four sessions of vFBT using the FBT Fidelity and Adherence Check (experts in FBT fidelity rating will rate the recordings).Measure: Fidelity Time: Completed after the session 4 of treatment, approximately 4 months
Description: Experiences of the therapists, medical practitioners, administrators, and families in vFBT, qualitatively measured during semi-structured focus groupsMeasure: Qualitative experience of participants Time: Completed after session 4 of treatment, approximately 4 months
Description: Weight will be measured in kilograms.Measure: Change in Weight Time: At baseline before treatment, and at 1 week, 2 weeks, 3 weeks, and 4 weeks.
Description: The number of binge/purge episodes each week will be recorded by patients/their families.Measure: Change in Number of Binge/Purge Episodes Time: At baseline before treatment, and at 1 week, 2 weeks, 3 weeks, and 4 weeks.
Description: The Brief Individual Readiness to Change Scale will indicate how ready therapists feel they are to change. Higher scores indicate greater readiness to use research-based direct service techniques. Minimum score is 0, maximum score is 20.Measure: Therapists' Change in Readiness Time: At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)
Description: Their attitudes about evidence-based practice will be assessed using the Evidence Based Practice Attitudes Scale (EBPAS). The subscales include requirements, appeal, openness and divergence. The score for each subscale is created by computing a mean score for the items that load on a given subscale. Minimum score for each subscale is 0, maximum score for each subscale is 4.Measure: Therapists' Change in Attitudes about Evidence Based Practice Time: At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)
Description: Their confidence related to the intervention will be assessed by administering an adapted version of the Perceived Attributes of the Principles of Effectiveness Scale (MPAS). Higher scores are indicative of more favorable perception for adoption of the Family-Based Treatment model. The minimum score is 18, the maximum score is 90.Measure: Therapists' Change in Confidence related to the Intervention Time: At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports